And in the end-Telmisartan directly binds to PPARγ

Hypertension Research

Volumn 35, Issue 7, 2012, Pages 704-705

  Kintscher, Ulrich ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; RAMIPRIL; ROSIGLITAZONE; TELMISARTAN;

CARDIOVASCULAR DISEASE; DIABETES MELLITUS; DRUG EFFICACY; DRUG PROTEIN BINDING; HEART INFARCTION; HUMAN; HYPERTENSION; LOW DRUG DOSE; METABOLIC SYNDROME X; NONHUMAN; NOTE; STROKE;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; BENZIMIDAZOLES; BENZOATES; HUMANS; PPAR GAMMA;

EID: 84863652325     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2012.35     Document Type: Note

References (9)

1. Benson SC, Pershadsingh HA, Ho CI, Chittiboyina A, Desai P, Pravenec M, Qi N, Wang J, Avery MA, Kurtz TW. Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity. Hypertension 2004; 43: 993-1002. (Pubitemid 38579904)
2. Schupp M, Clemenz M, Gineste R, Witt H, Janke J, Helleboid S, Hennuyer N, Ruiz P, Unger T Staels B, Kintscher U. Molecular characterization of new selective peroxisome proliferator-activated receptor {gamma} modulators with angiotensin receptor blocking activity. Diabetes 2005; 54: 3442-3452. (Pubitemid 43334334)
3. Schupp M, Janke J, Clasen R, Unger T, Kintscher U. Angiotensin type 1 receptor blockers induce peroxisome proliferator-activated receptor-gamma activity. Circulation 2004; 109: 2054-2057. (Pubitemid 38620211)
4. Kintscher U, Foryst-Ludwig A, Unger T. Inhibiting angiotensin type 1 receptors as a target for diabetes. Expert Opin Ther Targets 2008; 12: 1257-1263.
5. Yusuf S, Teo KK, Pogue J, Dyal L, Copland I, Schumacher H, Dagenais G, Sleight P, Anderson C. Telmisartan ramipril, or both in patients at high risk for vascular events. N Engl J Med 2008; 358: 1547-1559. (Pubitemid 351522739)
6. Bahr IN, Tretter P, Kruger J, Stark RG, Schimkus J, Unger T, Kappert K, Scholze J, Parhofer KG, Kintscher U. High-dose treatment with telmisartan induces monocytic peroxisome proliferator-activated receptorgamma target genes in patients with the metabolic syndrome. Hypertension 2011; 58: 725-732.
7. Amano Y, Yamaguchi T, Ohno K, Niimi T, Orita M, Sakashita H, Takeuchi M. Structural basis for telmisartan-mediated partial activation of PPAR gamma. Hypertens Res 2012; 35: 715-719.
8. Nolte RT, Wisely GB, Westin S, Cobb JE Lambert MH, Kurokawa R, Rosenfeld MG Willson TM, Glass CK, Milburn MV. Ligand binding and co-activator assembly of the peroxisome proliferatoractivated receptor-gamma. Nature 1998; 395: 137-143. (Pubitemid 28425645)
9. Goebel M, Clemenz M, Staels B, Unger T, Kintscher U, Gust R. Characterization of new PPARgamma agonists: analysis of telmisartan's structural components. Chem Med Chem 2009; 4: 445-456.